DJIA 17,067.56 -30.89 -0.18%
NASDAQ 4,598.19 17.92 0.39%
S&P 500 2,002.28 -1.09 -0.05%
market minute promo

Incyte Corp (NASDAQ: INCY)

53.12 -1.08 (-1.99%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

INCY $53.12 -1.99%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $54.50
Previous Close $54.20
Daily Range $52.50 - $54.50
52-Week Range $33.01 - $70.86
Market Cap $8.9B
P/E Ratio -63.02
Dividend (Yield) $0.00 (0.0%)
Volume 945,537
Average Daily Volume 875,251
Current FY EPS -$0.29

Sector

Healthcare

Industry

Drugs

Incyte Corp (INCY) Description

The Company is a drug discovery and development company focused on developing proprietary small molecule drugs to treat serious unmet medical needs. Website: http://www.incyte.com/

News & Commentary Rss Feed

3 Longtime Losers About to See Green?

These 3 biotechs have lost tons of money every year so far in the 21st century. But could profits be on the horizon?

Gilead: Let's Make A Deal

Earnings Estimates Moving Higher for Incyte Corporation (INCY): Time to Buy? - Tale of the Tape

Earnings Estimates Moving Higher for Incyte Corporation (INCY): Time to Buy? - Tale of the Tape

Bullish Two Hundred Day Moving Average Cross - INCY

3 Drugs Stocks Dragging The Industry Down

Incyte Posts Wider-than-Expected Q2 Loss, Raises Sales View - Analyst Blog

Incyte Posts Wider-than-Expected Q2 Loss, Raises Sales View - Analyst Blog

Incyte's (INCY) CEO Hervé Hoppenot on Q2 2014 Results - Earnings Call Transcript

Q2 2014 Incyte Corp Earnings Conference Call (Webcast)

Why Incyte (INCY) Might Surprise This Earnings Season - Tale of the Tape

UPDATE: Incyte Partners With Genetech to Help With Trials

ROTH Capital's Debjit Chattopadhyay: Marriage Of Diagnostics To New Therapies Breeds Biotech Winners

See More INCY News...

INCY's Top Competitors

INCY $53.12 (-1.99%)
Current stock: INCY
AMGN $137.96 (-1.02%)
Current stock: AMGN
GILD $109.36 (1.67%)
Current stock: GILD
BIIB $342.68 (-0.10%)
Current stock: BIIB